2026-01-18 - Analysis Report
## UnitedHealth Group Inc - UNH Financial Report

### Overview
UnitedHealth Group Inc is a diversified health insurance company.

### Return Comparison
| Ticker | Cumulative Return | Divergence |
|--------|-------------------|------------|
| UNH    | -21.52%           | -113.20    |
| VOO (S&P 500) | 93.36% | - |

* The cumulative return of UNH is -21.52% compared to 93.36% for VOO (S&P 500). 
* The degree of divergence is -113.20.

### Alpha-Beta Analysis
| Period | CAGR | MDD | Alpha | Beta | Cap (B) |
|--------|------|-----|-------|------|---------|
| 2016-2018 | 22.0% | 18.6% | 19.0% | 0.9 | 225.7  |
| 2017-2019 | 27.0% | 18.6% | 10.0% | 0.9 | 266.3  |
| 2018-2020 | -41.0% | 32.5% | -62.0% | 1.1 | 317.7  |
| 2019-2021 | 16.0% | 32.5% | -27.0% | 1.1 | 454.9  |
| 2020-2022 | 0.0% | 31.5% | 2.0% | 0.9 | 480.3  |
| 2021-2023 | 23.0% | 13.4% | 23.0% | 0.5 | 476.9  |
| 2022-2024 | -24.0% | 23.1% | -44.0% | 0.4 | 458.2  |
| 2023-2025 | -55.0% | 58.5% | -118.0% | 0.3 | 299.0  |

### Recent Stock Price
* Close: $331.02
* Last-market: -2.34
* 5-day SMA: $335.88
* 20-day SMA: $334.77
* 60-day SMA: $333.81

### Indicator Analysis
* Market Risk Indicator (MRI): 0.80
* RSI: 49.38
* PPO: -0.17
* Hybrid Signal: Buy
* Risk Level: Medium (MRI 0.80)
* Recent (20 days) relative divergence change: -1.70 (worsening)
* 7-day Rank change: -94 (rank down)
* 7-day Dynamic Expected Return change: -23.20 (worsening)
* Expected Return (%): -297.90%

### Recent News
- 'Top Healthcare Pick for 2026,' Says Bernstein on UnitedHealth Stock (UNH). Here’s Why
- UnitedHealth Faces New Medicare Accusations. What Does That Mean for UNH Stock?
- Trump says he is “getting rid” of healthcare middlemen
- Is UnitedHealth Group Stock a Buy, Sell, or Hold in 2026?
- As Trump Unveils His ‘Great Healthcare Plan,’ How Should You Play UnitedHealth Stock?
- Trump Just Took Aim at Health Insurance ‘Middlemen.’ What Does That Mean for UnitedHealth Stock?

### Analyst Opinions
* Analyst Consensus: 
    + Key: Buy
    + Mean: 1.93
    + Opinions: 26
    + Target Price (avg/high/low): 393.85 / 444.00 / 280.00

### Recent Earnings Analysis
| Date | EPS | Revenue |
|------|-----|---------|
| 2025-10-28 | 2.59 | $113.16B |
| 2025-08-11 | 3.76 | $111.62B |
| 2025-05-07 | 6.9 | $109.58B |
| 2024-11-04 | 6.56 | $100.82B |
| 2025-10-28 | 6.56 | $100.82B |

### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

### Comprehensive Analysis
UnitedHealth Group Inc has a negative cumulative return compared to the S&P 500 stock, indicating a divergence of -113.20. The company's recent stock price shows a 5-day SMA of $335.88, 20-day SMA of $334.77, and 60-day SMA of $333.81. The indicator analysis shows a market risk indicator of 0.80, RSI of 49.38, and PPO of -0.17, indicating a medium risk level. The expected return is -297.90%. Recent news includes various articles regarding the company's performance and potential effects of regulatory changes. Analyst opinions suggest a buy rating with a mean opinion of 1.93 and a target price of $393.85. The company's revenue and profitability show fluctuations, but generally increasing revenue and profit margins. The capital and profitability analysis shows fluctuations in equity and return on equity.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.